A Case of Xanthoma Disseminatum in a Progressive Form With Bladder Involvement Effectively Treated With 2-Chlorodeoxyadenosine
Keywords:
bladder, 2-chlorodeoxyadenosine, cladribine, xanthoma disseminatumReferences
Altman J, Winkelmann R. Xanthoma disseminatum. Arch Dermatol. 1962;86(5):582-596. DOI:10.1001/archderm.1962.01590110018003
Caputo R, Veraldi S, Grimalt R, et al. The various clinical patterns of xanthoma disseminatum. Dermatology. 1995;190(1):19-24. DOI: 10.1159/000246628. PMID: 7894090.
Zelger B, Cerio R, Orchard G, Fritsch P, Wilson-Jones E. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Dermatol. 1992;128(9):1207-1212. PMID: 1519935.
Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non‐Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45(3):256-264. DOI: 10.1002/pbc.20246. PMID: 15547923.
Khezri F, Gibson LE, Tefferi A. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series. Arch Dermatol. 2011;147(4):459-464. DOI: 10.1001/archdermatol.2010.378. PMID: 21173305.
Adışen E, Aladağ P, Özlem E, Gürer M. Cladribine is a promising therapy for xanthoma disseminatum. Clin Exp Dermatol. 2017;42(6):717-719. DOI: 10.1111/ced.13116. PMID: 28544144.
Published
Issue
Section
License
Copyright (c) 2023 Elçin Akdaş, Burcu Beksaç, Esra Adışen, Özlem Erdem, Murat Orhan Öztaş

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

